Get rich with a single! Amazon has won 8.1 billion orders, and its products are selling like crazy i

Recently, one of the biggest "dark horses" in 2021, Jiu'an Medical, once again detonated heated discussions on the entire Internet with just one announcement. Driven by the overseas epidemic, domestic IVD companies continue to set sail in overseas markets.
1 billion doses of COVID-19 testing gap per month
On Saturday, the U.S. government said that Americans will be able to pre-order free COVID-19 test kits online starting Jan. U.S. President Biden said that he has instructed the U.S. government to purchase an additional 500 million kits on top of the previous 500 million test kits, and the total purchase quantity will not be capped.

The White House said that the U.S. government has completed the procurement contract for 420 million kits in the first order, and the first 500 million orders are expected to cost $4 billion (average unit price of $8). In the next few weeks, the U.S. government may also award more contracts.

The purchase of 1 billion test kits may only be the beginning.

The U.S. government said: Beginning on January 15, 2022, the U.S. government officially implemented the new crown rapid test program, wherby private health insurance companies will reimburse each resident for up to 8 non-prescription home new crown tests per month. This means that a family of 4 can be reimbursed for up to 32 inspections per month.

According to the current population of 330 million in the United States and the insurance participation rate of medical insurance at 94%, if the home self-test plan is all carried out with antigen reagents, the monthly demand for antigen reagents in the United States is close to 2.5 billion doses, even if the proportion of antigen reagents is used. It is 50%, and the monthly demand is also around 1.2 billion doses.

The current high number of confirmed diagnoses in the United States has made the United States the market with the largest demand for new crown testing in the world. Chinese manufacturers that have been approved in the United States or will be approved in the future are expected to usher in a substantial increase in performance in this round of epidemics.

Jiu'an Medical signed a large order of 8.1 billion with the United States

iHealth, a big brand of Amazon medical supplies, is a brand of Jiu'an Medical. It sells blood pressure monitors, blood glucose meters, forehead thermometers, test kits and other popular medical products, which often appear on Amazon's BSR lists in various categories. On January 14, 2022, Jiu'an Medical announced that it has won another large overseas order with an amount of about 8.1 billion yuan!

According to the announcement, on January 13, 2022 local time, the US subsidiary of Jiu'an Medical and the US ACC signed a "Procurement Contract" to sell iHealth kit products to it. The total contract price and tax amounted to 1.275 billion US dollars, or about RMB 81 100 million yuan, which has exceeded 50% of the company's audited main business income in 2020.

It is worth noting that the US ACC is the main subordinate contract management department of the US Army Materiel Command, which mainly undertakes most of the contract work for the US Army.

As we all know, most of China's new crown testing products are for civilian use, and this is the first time they have been sold to the US military. From this perspective, the order of Jiu'an Medical is of great significance.

What level is this 8.1 billion contract? In 2020, Jiu'an Medical's annual operating income is about 2 billion yuan, and the total product revenue of the iHealth brand is about 1.4 billion yuan.

In other words, 2022 has just started, and the iHealth order will top the income of the past 4 years.

The operation mode of iHealth in the Jiu'an medical system is that the parent company in Tianjin sells to overseas subsidiaries first, and then the overseas subsidiaries are responsible for overseas sales. For example, iHealth America is responsible for product sales and promotion in the Americas, and iHealth Europe is responsible for sales and promotion in the European market and the adjacent African and Middle East markets. The Hong Kong subsidiary is responsible for the sales and promotion of iHealth products in other overseas regions other than Europe and the United States.

In September 2014, iHealth introduced Xiaomi's US$25 million investment and became Xiaomi's partner in the health field.

During the new crown epidemic, the products surrounding the epidemic frequently experienced burst orders. In July 2020, the iHealth forehead thermometer product once sold 20,502 units in a single day on the Amazon platform.

Until now, the iHealth brand is still a frequent customer of No.1 BSR in the baby temperature measurement product category, the forehead thermometer product in high demand.

Therefore, the performance of Jiu'an Medical in 2020 is also very bright. That year, the operating income reached 2.008 billion yuan, a year-on-year increase of 184.36%, and the net profit attributable to shareholders of the listed company was 242 million yuan, a year-on-year increase of 264.68%.

By the end of 2021, Omicron will swept across the United States, and the number of new cases every day is increasing by hundreds of thousands or even millions. iHealth New Crown Antigen Home Self-Assessment OTC Kit has suddenly become popular! In the sub-category ranking of self-test kits on Amazon's US station, iHealth once soared to the top!

This is not the first time that Jiu'an Medical has won a purchase order for new crown reagents in the United States.

On the evening of January 12, 2022, Jiu'an Medical issued an announcement saying that on December 21, 2021 local time, it received two copies of the New York State Department of Health and the New York State non-profit organization Health Research. Incorporated's purchase order for iHealth New Crown Antigen Home Self-Assessment OTC Kit, the order amount is US$25.08 million (including shipping) and US$40.23 million (including shipping), with a total order value of US$65.31 million (including shipping), approximately RMB 416 million yuan.

In addition, the company and the New York State Department of Health signed a "sales contract" on January 10, 2022, local time, to sell iHealth kit products to the New York State Department of Health, the total contract price and tax amounted to 120 million US dollars (including freight) , about RMB 764 million.

Jiu'an Medical has been authorized by the FDA again

Jiu'an Medical announced that on January 15, 2022, local time, the subsidiary company's new coronavirus antigen rapid detection professional version kit obtained Emergency Use Authorization (EUA), and received the US Food and Drug Administration (FDA) to iHealth Authorization letter sent from the United States.

Up to now, only the rapid detection reagents produced by the three domestic companies, Jiu'an Medical, Oriental Bio, and Aikang Bio, can enter the US market. At the same time, rapid detection reagent products from companies including Meikang Bio, Botop Bio, Wantai Bio and Wanfu Bio are also applying for FDA certification in the United States. Considering the complexity of certification, the earliest approval of relevant certification may not wait until the end of the first quarter of 2022.

last words

There is no doubt that, driven by the current round of overseas epidemics, after the implementation of the new crown rapid test plan of the US government, major domestic new crown testing companies will further expand their capacity in overseas markets.

In particular, Chinese manufacturers that have been approved or are about to be approved in the United States are expected to reap very considerable performance growth in this round of epidemics.

Perhaps for most sellers, looking at such a giant, probably only envy. But don’t forget that some methodologies may still be used for reference, such as being good at taking advantage of the trend, such as expanding the C-end brand to obtain stable profits through the B-end.

In 2022, I hope that more sellers will be able to make big orders like iHealth every day!